Skip to main content
. 2019 Mar 27;77(2):ftz016. doi: 10.1093/femspd/ftz016

Table 3.

Statistical comparisons of cytokines and chemokines among WNV-positive cases and WNV-negative controls by sex.

Females vs males, P valuea
Cytokine/Chemokineb Controls (n1 = 14, n2 = 17)c IgM-negative cases (n1 = 32, n2 = 32)c IgM-positive cases (n1 = 15, n2 = 36)c
CCL2 (MCP-1) 0.7614 0.0507 0.0014
CCL7 (MCP-3) 0.0140 0.4141 0.8392
CCL8 (MCP-2) 0.1830 0.8860 0.1477
CCL11 (eotaxin-1) 0.4685 0.0176 0.0021
CCL13 (MCP-4) 0.0971 0.7802 0.2583
CCL20 (MIP-3α) 0.0632 0.3938 0.8764
CXCL9 (MIG) 0.1304 0.0745 0.145
CXCL10 (IP-10) 0.0444 0.4055 0.0278
IFN-α 0.4516 0.4628 0.2925
IL-15 0.5353 0.3794 0.0099
IL-1RA 0.0005 0.9389 0.4943
MMP-9 0.4213 0.7439 0.1297

Abbreviations: IFN-α, interferon α; IgM, immunoglobulin M; IL-15, interleukin 15; IL-1RA, interleukin 1 receptor antagonist; IP-10, interferon γ-induced protein 10; MCP, monocyte chemoattractant protein; MIG, monokine induced by gamma interferon; MIP-3α, macrophage inflammatory protein 3α; WNV, West Nile virus.

a

Determined by the Mann–Whitney U test. Values <0.05 are considered statistically significant.

b

The significance pattern of cytokine level differences among controls, pre-IgM cases and post-IgM cases were compared between sexes. Cytokines that did not show sex differences in cytokine level comparisons are not shown.

c

Number of females (n1) and males (n2) in each group.